Cleviprex OverviewClevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. It was approved by the United States Food and Drug Administration on August 1, 2008. Contents 1 Basic chemical and pharmacological properties 1.1 Stereochemistry 2 Dosage and administration 3 Safety information 4 Drug interactions 5 Storage 6 Phase III clinical trial results 7 References ...
Read more Cleviprex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Clevidipine
Recent Cleviprex Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Emulsion: 0.5mg/ml, 125mg/250ml (0.5mg/ml), 25mg/50ml (0.5mg/ml), 25mg/50ml(0.5mg/ml), 50mg/100ml (0.5mg/ml), 50mg/100ml(0.5mg/ml)
NDC Database Records for Cleviprex: (5 results)Sorted by National Drug Code
- 10122-610 Cleviprex .5 mg/ml Intravenous Emulsion by Chiesi USA, Inc.
- 10122-611 Cleviprex .5 mg/ml Intravenous Emulsion by Chiesi USA, Inc.
- 10122-612 Cleviprex .5 mg/ml Intravenous Emulsion by Chiesi USA, Inc.
- 18124-011 Cleviprex .5 mg/ml Intravenous Emulsion by Fresenius Kabi Austria Gmbh
- 65293-005 Cleviprex .5 mg/ml Intravenous Emulsion by The Medicines Company